Inspire Medical Systems (INSP) Long-Term Deferred Tax (2017 - 2026)

Inspire Medical Systems (INSP) posted Long-Term Deferred Tax of $87.7 million for Q1 2026, down 1.13% sequentially from $88.7 million in Q4 2025.

Inspire Medical Systems (INSP) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends

Inspire Medical Systems has reported Long-Term Deferred Tax for 5 years, with the latest figure at $87.7 million in Q1 2026.

Quarterly Long-Term Deferred Tax changed N/A year-over-year to $87.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87.7 million (changed N/A YoY) and the FY2025 annual result came in at $88.7 million, up 681953.85% from the prior year.
Long-Term Deferred Tax fell to $87.7 million in Q1 2026 per INSP's latest filing, from $88.7 million in the prior quarter.
Over five years, Long-Term Deferred Tax peaked at $88.7 million in Q4 2025 and troughed at $13000.0 in Q4 2024.
A 3-year average of $58.8 million and a median of $87.7 million in 2026 frame the typical range for Long-Term Deferred Tax.
The widest YoY moves for Long-Term Deferred Tax: up 681953.85% in 2025, down 681953.85% in 2025.
Over 3 years, Long-Term Deferred Tax stood at $13000.0 in 2024, then soared by 681953.85% to $88.7 million in 2025, then fell by 1.13% to $87.7 million in 2026.
According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $87.7 million, $88.7 million, and $13000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Inspire Medical Systems	1.80 Bn	1.48 Bn	171.46 Mn

Download Data